NCT00905047 - Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2010

Study Completion Date

September 30, 2011

Conditions

Colorectal Cancer

Interventions

DRUG

XELODA

"XELODA, 2500 mg/m²/bid, with approximatively an interval of 12 hours, 30 minutes after breakfast and dinner - during 14 days.~Cycle treatment duration : 21 days"

DRUG

TEGAFUR URACIL - FOLINIC ACID

"Tegafur 300 mg/m2/tid with folinic acid 75 mg/tid during 28 days.~Duration of treatment cycle : 35 days."

Trial Locations (13)

49033

Centre Paul Papin, Angers

49300

Centre Hospitalier de CHOLET, Cholet

59000

Polyclinique du Bois, Lille

59020

Centre Oscar Lambret, Lille

Hopital Saint Vincent de Paul, Lille

59035

Centre Hospitalier Regional, Lille

59100

Centre Hospitalier, Roubaix

59187

Centre Leonard de Vinci, Dechy

59280

Centre Hospitalier, Armentières

59300

Centre Hospitalier, Valenciennes

Clinique des Dentellieres, Valenciennes

62280

Centre Joliot-Curie, Saint Martin Les Boulogne

62660

Centre Hospitalier de Béthune, Beuvry

All Listed Sponsors

lead

Centre Oscar Lambret

OTHER